Psoriasis: The Blood Tests That Reveal the Hidden Risks

Why Psoriasis Might Be More Than You Think

If you have psoriasis, you've probably focused on treating the visible skin symptoms with topical creams, phototherapy, or systemic medications. Your dermatologist may have discussed flare management and skin care routines. But here's what's crucial to understand: psoriasis is not just a skin disease. It's a systemic inflammatory condition that increases your cardiovascular risk by 50%. Your psoriasis skin lesions are visible evidence of underlying systemic inflammation affecting your heart, blood vessels, and metabolic health. Blood work reveals this hidden cardiovascular and metabolic risk, transforming psoriasis from a cosmetic concern into a serious health issue requiring comprehensive management.

Many people with psoriasis have undiagnosed metabolic syndrome, a combination of insulin resistance, abnormal lipids, and elevated blood pressure that dramatically increases heart attack and stroke risk. Yet this metabolic dysfunction is frequently not investigated or addressed in psoriasis management. Understanding your full metabolic profile transforms your ability to prevent serious cardiovascular complications.

What Your Body Might Be Telling You

Psoriasis involves abnormally rapid skin cell turnover and immune system dysfunction creating excessive inflammation. This inflammatory process is not isolated to the skin; it's a systemic inflammatory state affecting your entire body. CRP (C-reactive protein), an inflammatory marker, is elevated in 30-40% of psoriasis patients, indicating systemic inflammation beyond just skin inflammation.

Metabolic syndrome co-occurs with psoriasis in up to 40% of cases. Metabolic syndrome includes insulin resistance, abdominal obesity, abnormal cholesterol (high triglycerides, low HDL), elevated blood pressure, and elevated fasting glucose. Each component independently increases cardiovascular risk; together they create dramatically elevated risk. Yet metabolic syndrome often goes undiagnosed in psoriasis patients because doctors focus on skin treatment without investigating metabolic function.

Uric acid is elevated in psoriasis due to rapid skin cell turnover. Dead skin cells release nucleotides that break down into uric acid. This elevation increases gout risk, a problem many psoriasis patients face. Uric acid above 7 mg/dL creates crystal deposition risk; above 9 creates acute gout risk.

Liver enzyme elevation occurs in psoriasis patients, particularly those on systemic medications like methotrexate or biologics. Regular monitoring protects against medication toxicity. Kidney function can also be affected by systemic psoriasis and requires monitoring.

Depression and anxiety co-occur in psoriasis at rates much higher than the general population. The systemic inflammation of psoriasis may contribute to psychiatric symptoms through cytokine effects on the brain.

The Blood Tests That Can Help

hs-CRP (high-sensitivity C-reactive protein) measures systemic inflammation. Above 3 mg/L indicates elevated cardiovascular risk. In psoriasis patients, elevated hs-CRP indicates not just skin inflammation but systemic inflammation affecting your entire cardiovascular system.

Fasting glucose and HbA1c reveal diabetes and prediabetes. HbA1c above 5.7% indicates prediabetes; above 6.5% indicates diabetes. Elevated fasting insulin indicates insulin resistance, a key component of metabolic syndrome.

Lipid panel including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides shows cardiovascular risk factors. High triglycerides above 200 mg/dL combined with low HDL below 40 mg/dL (men) or 50 mg/dL (women) indicate metabolic dysfunction.

Uric acid testing reveals elevation from rapid skin cell turnover. Above 7 mg/dL creates gout risk; above 9 indicates acute flare potential.

Liver function tests including ALT, AST, ALP, and bilirubin are essential for patients on systemic psoriasis medications. Baseline testing before starting medications establishes normal values for comparison.

Complete blood count (CBC) monitors white blood cells and platelets, important in immunosuppressive therapy. Kidney function through creatinine and eGFR ensures safe medication use.

TSH screening identifies hypothyroidism, which is more common in psoriasis patients and worsens inflammatory state. Comprehensive metabolic panel (CMP) provides overall metabolic assessment.

The Key Insight Your GP Might Miss

The critical insight that changes everything is this: psoriasis is a systemic inflammatory condition increasing cardiovascular mortality by 50%. Yet many dermatologists treat psoriasis purely as a skin disease without ever ordering cardiovascular risk assessment. A psoriasis patient with elevated hs-CRP, elevated fasting insulin, abnormal lipids, and elevated blood pressure has dramatically elevated risk for heart attack and stroke, yet this cardiovascular risk is often completely unaddressed.

Additionally, metabolic syndrome in psoriasis patients is undertreated. Many people with psoriasis have insulin resistance, abnormal lipids, and elevated blood pressure that could be managed with diet, exercise, and lifestyle modifications, potentially improving their psoriasis simultaneously. Yet because dermatologists focus on skin treatment and internists don't know about the psoriasis-metabolic syndrome connection, the metabolic dysfunction goes unmanaged.

Finally, the gout connection in psoriasis is important. Uric acid elevation from rapid skin turnover increases gout risk. Some psoriasis patients experience repeated gout attacks without understanding that their psoriasis is driving the uric acid elevation. Managing uric acid in psoriasis patients prevents these painful flares.

Red Flags to Watch For

hs-CRP above 3 mg/L indicates elevated cardiovascular risk from systemic inflammation. This finding warrants aggressive cardiovascular risk factor management.

HbA1c above 6.5% or fasting glucose above 126 mg/dL indicates diabetes. Combined with psoriasis and elevated inflammatory markers, this indicates severe metabolic dysfunction requiring aggressive intervention.

Triglycerides above 200 mg/dL with HDL below 40 mg/dL (men) or 50 mg/dL (women) indicates metabolic syndrome. This combination with elevated hs-CRP creates very high cardiovascular risk.

Uric acid above 9 mg/dL with psoriasis indicates gout flare risk and requires aggressive urate-lowering therapy. Liver enzymes elevated above 3 times normal in a patient on psoriasis medications warrant medication adjustment or discontinuation.

How to Talk to Your Doctor

Here's your script: "I have psoriasis and I'm interested in understanding my overall cardiovascular and metabolic risk. Could we run hs-CRP, fasting glucose, HbA1c, fasting insulin, lipid panel, uric acid, TSH, comprehensive metabolic panel, and liver function tests? I want to know if I have metabolic syndrome or elevated cardiovascular risk from my psoriasis-related inflammation."

If you're starting systemic psoriasis treatment, add: "I'm starting a new psoriasis medication. What baseline blood tests should we do to monitor for side effects? How often should I have follow-up testing?"

If metabolic dysfunction is identified, ask: "My results show metabolic syndrome with elevated inflammation. Could improving my metabolic health also improve my psoriasis? What diet and lifestyle changes would help?"

Take Control of Your Health

Psoriasis is more than a skin condition; it's a signal that your body is dealing with systemic inflammation and metabolic dysfunction. By investigating and managing your cardiovascular and metabolic risk factors, you don't just protect your overall health; you often improve your psoriasis simultaneously. Comprehensive blood work gives you the information you need to address both the visible and invisible aspects of your condition.

Understand your blood tests for psoriasis! Upload it at MeBlood.com